3D-Printed Vancomycin- and Gentamicin-Loaded Bone Grafts for Osteomyelitis Treatment: Drug Release and Antibacterial Efficacy
ACS Omega · 18.08.2026 · 11 (32) · 48344-48360
DOI: 10.1021/acsomega.6c04993 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 03.08.2026. Verfasst von Oguz Sogut und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Pharmacology, Medicine, Medical Device and Dermocosmetic Research and Application Laboratory-IDAL, 32260 Isparta, …. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: S??leyman Demirel ??niversitesi, Y??ksek??gretim Kurulu, T??rkiye Bilimsel ve Teknolojik Arastirma Kurumu.
Abstract (Originalsprache)
In this study, the potential of 3D printing technology for patient-adaptable osteomyelitis treatment was determined as well as the effects of antibiotic-loaded grafts on physicochemical properties, thermal stability, antimicrobial efficacy, and cell viability were evaluated. Polycaprolactone (PCL) and nanohydroxyapatite (HA) were used as the backbone of 3D grafts using different models, including Grid, Tri-Hexagon, Zigzag, and Gyroid. Later, gentamicin (10% and 15%), vancomycin (10% and 15%), and their combinations (5%–5% and 7.5%–7.5%) were added to the selected model graft. X-ray diffraction, thermal characterization, Fourier transform infrared spectroscopy (FTIR), and Raman spectroscopy analyses were conducted to characterize the obtained filament before 3D printing. The interaction of drugs and HA within the composite filaments was confirmed by FTIR and Raman spectroscopy. Thermal studies showed that the optimal temperature range for 3D printing did not disturb the structural integrity of the grafts. Cell viability and cytotoxicity assays also confirmed sustained cell viability, as well as those mentioned drug-loaded filaments’ tests showed antibacterial effects against osteomyelitis-causing pathogens (Staphylococcus aureus, Escherichia coli). This study demonstrated the potential of combining 3D printing technology with localized drug delivery systems to enhance osteomyelitis treatment by providing patient-adaptable scaffold architectures that maximize drug efficacy and minimize systemic side effects, representing a promising strategy that warrants further preclinical validation before clinical translation.
Autor:innen und Institutionen
- Faculty of Medicine, Department of Pharmacology, Medicine, Medical Device and Dermocosmetic Research and Application Laboratory-IDAL, 32260 Isparta, Turkey.
- Suleyman Demirel University, Natural Products Application and Research Center, 32200 Isparta, Turkey.
- Suleyman Demirel University, Institute of Health Sciences, Department of Regenerative Medicine, 32200 Isparta, Turkey.
ORCID-Profile: Oguz Sogut
Förderung
- S??leyman Demirel ??niversitesi
- Y??ksek??gretim Kurulu
- T??rkiye Bilimsel ve Teknolojik Arastirma Kurumu
Zitieren
APA
Sogut, O., & Sezer, U. A. (2026). 3D-Printed Vancomycin- and Gentamicin-Loaded Bone Grafts for Osteomyelitis Treatment: Drug Release and Antibacterial Efficacy. ACS Omega, 11(32), 48344-48360. https://doi.org/10.1021/acsomega.6c04993
Vancouver
Sogut O, Sezer UA. 3D-Printed Vancomycin- and Gentamicin-Loaded Bone Grafts for Osteomyelitis Treatment: Drug Release and Antibacterial Efficacy. ACS Omega. 2026;11(32):48344-48360. doi:10.1021/acsomega.6c04993
BibTeX
@article{Sogut2026,
author = {Sogut, Oguz and Sezer, Umran Aydemir},
title = {3D-Printed Vancomycin- and Gentamicin-Loaded Bone Grafts for Osteomyelitis Treatment: Drug Release and Antibacterial Efficacy},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {32},
pages = {48344--48360},
doi = {10.1021/acsomega.6c04993}
}
EUVIMED